Evidence map›Paper›PMID 35477991›Full record

ArticleCell death and differentiation2022

GSK3β mediates the spatiotemporal dynamics of NLRP3 inflammasome activation.

Suyavaran Arumugam, Yanqin Qin, Ziwen Liang, Sheng-Na Han, S L Tejaswi Boodapati, Junzi Li, Qiuxia Lu, Richard A Flavell, Wajahat Z Mehal, Xinshou Ouyang

Open access · bronzeAbstract read
In one paragraph

Article in Cell death and differentiation, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 28 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
28citing papers in PubMed, 1 pooled it
3.3field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

28 citing papers in PubMed, 1 synthesis or guideline pooled it, 39 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Review
  4. Review
  5. Review
  6. Article
  7. Review
  8. Review
  9. Diverse Scaffolds Facilitate NLRP3 Clustering and Inflammasome Formation in Response to Perturbations in Cell Homeostasis.BioEssays : news and reviews in molecular, cellular and developmental biology · 2026
    Review
  10. Review
  11. Review
  12. Review
  13. Review
  14. Article
  15. Review
  16. The Mechanisms of Lithium Action: The Old and New Findings.Pharmaceuticals (Basel, Switzerland) · 2025
    Review
  17. Article
  18. Review
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 3 institutions in 2 countries.

Suyavaran ArumugamDepartment of Internal Medicine, Section of Digestive Diseases, Yale University School of Medicine, New Haven, CT, 06520, USA.
Yanqin QinDepartment of Internal Medicine, Section of Digestive Diseases, Yale University School of Medicine, New Haven, CT, 06520, USA.
Ziwen LiangDepartment of Endocrinology, First Affiliated Hospital of Army Medical University (Third Military Medical University), Chongqing, 400038, China.
Sheng-Na HanDepartment of Internal Medicine, Section of Digestive Diseases, Yale University School of Medicine, New Haven, CT, 06520, USA.
S L Tejaswi BoodapatiDepartment of Internal Medicine, Section of Digestive Diseases, Yale University School of Medicine, New Haven, CT, 06520, USA.
Junzi LiDepartment of Internal Medicine, Section of Digestive Diseases, Yale University School of Medicine, New Haven, CT, 06520, USA.
Qiuxia LuDepartment of Internal Medicine, Section of Digestive Diseases, Yale University School of Medicine, New Haven, CT, 06520, USA.
Richard A FlavellDepartment of Immunobiology, Yale University School of Medicine, New Haven, CT, 06520, USA.ORCID 0000-0003-4461-0778
Wajahat Z MehalDepartment of Internal Medicine, Section of Digestive Diseases, Yale University School of Medicine, New Haven, CT, 06520, USA. wajahat.mehal@yale.edu.ORCID 0000-0001-8481-3671
Xinshou OuyangDepartment of Internal Medicine, Section of Digestive Diseases, Yale University School of Medicine, New Haven, CT, 06520, USA. xinshou.ouyang@yale.edu.ORCID 0000-0003-3423-0042
Yale University · USArmy Medical University · CNHoward Hughes Medical Institute · US

Funding

Yale Clinical and Translational Science Award (U Component)UL1TR001863 · NCATS · YALE UNIVERSITY · PI John H. Krystal, LUCILA OHNO-MACHADO · 2016 to 2026
$102.9M
Yale Diabetes Research CenterP30DK045735 · NIDDK · YALE UNIVERSITY · PI Kevan C Herold, GERALD I SHULMAN · 1993 to 2026
$44.0M
Yale Liver CenterP30DK034989 · NIDDK · YALE UNIVERSITY · PI MICHAEL H NATHANSON · 1986 to 2026
$31.1M
Interactions between neutrophils and cholangiocytes in alcoholic hepatitisR01AA028765 · NIAAA · YALE UNIVERSITY · PI NATHANSON, MICHAEL H · 2021 to 2025
$3.5M
The Inflammasome as a novel mediator and therapeutic target of GI syndromeR01CA224023 · NCI · YALE UNIVERSITY · PI FLAVELL, RICHARD A · 2018 to 2022
$1.9M
Inhibition of Sterile Inflammation by Digoxin in Alcoholic HepatitisU01AA026962 · NIAAA · YALE UNIVERSITY · PI MEHAL, WAJAHAT ZAFAR · 2018 to 2022
$1.2M
Regulation of Liver Fibrosis by Pyruvate Kinase M2 (PKM2)I01BX003259 · VA · VA CONNECTICUT HEALTHCARE SYSTEM · PI WAJAHAT Zafar MEHAL · 2017 to 2026
–
BLRD VA I01 BX003259NCATS NIH HHS UL1 TR001863NCI NIH HHS R01 CA224023NIAAA NIH HHS R01 AA028765NIAAA NIH HHS U01 AA026962NIDDK NIH HHS P30 DK034989NIDDK NIH HHS P30 DK045735
6 · The paper itself

Abstract

Subcellular machinery of NLRP3 is essential for inflammasome assembly and activation. However, the stepwise process and mechanistic basis of NLRP3 engagement with organelles remain unclear. Herein, we demonstrated glycogen synthase kinase 3β (GSK3β) as a molecular determinant for the spatiotemporal dynamics of NLRP3 inflammasome activation. Using live cell multispectral time-lapse tracking acquisition, we observed that upon stimuli NLRP3 was transiently associated with mitochondria and subsequently recruited to the Golgi network (TGN) where it was retained for inflammasome assembly. This occurred in relation to the temporal contact of mitochondria to Golgi apparatus. NLRP3 stimuli initiate GSK3β activation with subsequent binding to NLRP3, facilitating NLRP3 recruitment to mitochondria and transition to TGN. GSK3β activation also phosphorylates phosphatidylinositol 4-kinase 2 Α (PI4k2A) in TGN to promote sustained NLRP3 oligomerization. Our study has identified the interplay between GSK3β signaling and the organelles dynamics of NLRP3 required for inflammasome activation and opens new avenues for therapeutic intervention.

Indexed as

InflammasomesNLR Family, Pyrin Domain-Containing 3 Protein1-Phosphatidylinositol 4-KinaseGlycogen Synthase Kinase 3 betaGolgi Apparatus1-Phosphatidylinositol 4-KinaseGlycogen Synthase Kinase 3 betaInflammasomesNLR Family, Pyrin Domain-Containing 3 Protein

Identifiers

PMID35477991
PMCPMC9525599
OpenAlexW4224949143

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.